- Presentations
- 2
- Markets
- 1
Imaavy is a brand of Nipocalimab marketed by Janssen Biotech, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Nipocalimab
- Brand owner
- Janssen Biotech
- Registered in
- United States
- Strengths and forms
- 1202.5 mg/6.5 mL injection, 299.7 mg/1.62 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Imaavy 1202.5 mg/6.5 mL injectionIntravenous Cold chain | Janssen Biotech | US FDA | Available on request |
| Imaavy 299.7 mg/1.62 mL injectionIntravenous Cold chain | Janssen Biotech | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Imaavy
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.